BioStock: Aptahem has identified a mechanism of action for Apta-1

Since 2019, Aptahem has collaborated with the Cardiovascular Research Centre (CVRC) at Örebro University to better understand certain mechanisms behind Apta-1's effect. Now the collaboration has borne fruit by identifying and clarifying a mechanism of action for the drug candidate Apta-1. BioStock contacted Luiza Jedlina, CSO at Aptahem, to find out more about what this means for Aptahem.

Read the full article at biostock.se: 

https://www.biostock.se/en/aptahem-has-identified-a-mechanism-of-action-for-apta-1/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se